Articles in section Licensing
| << Joint Venture | 527 articles | Mergers & Acquisitions >> |
| Pages 1 2 3 4 5 .. 53 | Next >> |
-
GSK Signs US$2.7B+ Licensing Pact with ABL Bio for Neurodegenerative Diseases
-
Novo Nordisk Partners with The United Laboratories for US$2 B Cardiometabolic Drug Development
-
Roche Pays Zealand Pharma US$1.65 B Upfront for Obesity Drug Petrelintide
-
AbbVie Enters Obesity Space Through US$2.2 B Licensing Pact with Gubra
-
Biogen Gains Rights to Stoke Therapeutics’ Zorevunersen for the Treatment of Dravet Syndrome
-
GSK Signs US$1 B+ Partnerships with Duality Biologics and Rgenta Therapeutics
-
Novartis Pays US$150 M Upfront for Monte Rosa’s Molecular Glue Degrader
-
Astellas Pays US$30 M Upfront for AviadoBio’s AAV-based Gene Therapy AVB-101
-
Sanofi Pays RadioMedix and Orano Med US$110 M Upfront for Radioligand Medicine
-
Roche Signs US$1.82 B Deal with Ascidian for RNA-Targeting Neurology Programmes
RSS